JP2011509282A5 - - Google Patents

Download PDF

Info

Publication number
JP2011509282A5
JP2011509282A5 JP2010541840A JP2010541840A JP2011509282A5 JP 2011509282 A5 JP2011509282 A5 JP 2011509282A5 JP 2010541840 A JP2010541840 A JP 2010541840A JP 2010541840 A JP2010541840 A JP 2010541840A JP 2011509282 A5 JP2011509282 A5 JP 2011509282A5
Authority
JP
Japan
Prior art keywords
furo
benzamide
pyrrole
oxodihydro
oxopentan
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2010541840A
Other languages
English (en)
Japanese (ja)
Other versions
JP5587790B2 (ja
JP2011509282A (ja
Filing date
Publication date
Priority claimed from GB0800338A external-priority patent/GB0800338D0/en
Priority claimed from GB0808669A external-priority patent/GB0808669D0/en
Application filed filed Critical
Priority claimed from PCT/GB2009/000039 external-priority patent/WO2009087379A2/en
Publication of JP2011509282A publication Critical patent/JP2011509282A/ja
Publication of JP2011509282A5 publication Critical patent/JP2011509282A5/ja
Application granted granted Critical
Publication of JP5587790B2 publication Critical patent/JP5587790B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2010541840A 2008-01-09 2009-01-07 化合物 Expired - Fee Related JP5587790B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GB0800338.6 2008-01-09
GB0800338A GB0800338D0 (en) 2008-01-09 2008-01-09 Compounds
GB0808669.6 2008-05-13
GB0808669A GB0808669D0 (en) 2008-05-13 2008-05-13 Compounds
PCT/GB2009/000039 WO2009087379A2 (en) 2008-01-09 2009-01-07 Tetrahydrofuro (3, 2 -b) pyrrol- 3 -one derivatives as inhibitors of cysteine proteinases

Publications (3)

Publication Number Publication Date
JP2011509282A JP2011509282A (ja) 2011-03-24
JP2011509282A5 true JP2011509282A5 (https=) 2012-02-23
JP5587790B2 JP5587790B2 (ja) 2014-09-10

Family

ID=40791443

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2010541840A Expired - Fee Related JP5587790B2 (ja) 2008-01-09 2009-01-07 化合物

Country Status (4)

Country Link
US (3) US8501744B2 (https=)
EP (2) EP2719700A1 (https=)
JP (1) JP5587790B2 (https=)
WO (1) WO2009087379A2 (https=)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU581929B2 (en) * 1985-09-16 1989-03-09 Schering Corporation Antihypertensive agents, pharmaceutical compositions containing them and processes for the preparation of the agents and compositions
GB0817424D0 (en) 2008-09-24 2008-10-29 Medivir Ab Protease inhibitors
AU2013305759C1 (en) 2012-08-23 2018-01-18 Janssen Biopharma, Inc. Compounds for the treatment of paramoxyvirus viral infections
WO2014111465A1 (en) 2013-01-17 2014-07-24 Sanofi Isomannide derivatives as inhibitors of soluble epoxide hydrolase
NZ716822A (en) * 2013-08-21 2017-10-27 Alios Biopharma Inc Antiviral compounds
WO2015038655A1 (en) 2013-09-12 2015-03-19 Alios Biopharma, Inc. Aza-pyridone compounds and uses thereof
MA41614A (fr) 2015-02-25 2018-01-02 Alios Biopharma Inc Composés antiviraux
GB201506658D0 (en) 2015-04-20 2015-06-03 Cellcentric Ltd Pharmaceutical compounds
GB201506660D0 (en) 2015-04-20 2015-06-03 Cellcentric Ltd Pharmaceutical compounds

Family Cites Families (61)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3444216A (en) 1966-11-16 1969-05-13 Upjohn Co Process for the oxidation of primary and secondary alcohols
NZ207394A (en) 1983-03-08 1987-03-06 Commw Serum Lab Commission Detecting or determining sequence of amino acids
US5128448A (en) 1990-01-10 1992-07-07 Hoffman-La Roche Inc. CCK analogs with appetite regulating activity
US5374623A (en) 1992-08-20 1994-12-20 Prototek, Inc. Cysteine protease inhibitors effective for in vivo use
CA2111930A1 (en) 1992-12-25 1994-06-26 Ryoichi Ando Aminoketone derivatives
DZ2285A1 (fr) 1996-08-08 2002-12-25 Smithkline Beecham Corp Inhibiteurs de protéase de la cystéine.
US6043218A (en) 1996-10-22 2000-03-28 Medical University Of South Carolina Positively charged non-natural amino acids, methods of making thereof, and use thereof in peptides
AR013079A1 (es) 1997-05-06 2000-12-13 Smithkline Beecham Corp Derivados sustituidos de tetrahidrofurano-3-onas, de tetrahidropirano-3- onas y tetrahidrotiofen-3-onas, un procedimiento para su preparacion unacomposicion farmaceutica de un medicamento util como inhibidores de proteasas e intermediarios
TR200001189T2 (tr) 1997-11-05 2000-09-21 Novartis Ag. Dipeptid nitriller.
GB9806287D0 (en) 1998-03-24 1998-05-20 Synphar Lab Inc Monobactam enzyme inhibitors
MA26618A1 (fr) 1998-04-09 2004-12-20 Smithkline Beecham Corp Composes et compositions pharmaceutiques pour le traitement du paludisme
DZ2815A1 (fr) 1998-06-12 2003-12-01 Smithkline Beecham Corp Inhibiteurs de protéase.
JP2003527819A (ja) 1998-08-14 2003-09-24 スミスクライン・ビーチャム・コーポレイション カテプシンｋの阻害方法
ES2142773B1 (es) 1998-10-07 2001-01-01 Lacer Sa Derivados de mononitrato de isosorbida y su empleo como agentes vasodilatadores con tolerancia desminuida.
CO5150165A1 (es) 1998-11-13 2002-04-29 Smithkline Beecham Plc Inhibidores de proteasa: tipo catepsina k
EP1155010A1 (en) 1999-02-20 2001-11-21 AstraZeneca AB Acetamido acetonitrile derivatives as inhibitors of cathepsin l and/or cathepsin s
AU2560000A (en) 1999-02-20 2000-09-04 Astrazeneca Ab Di- and tripeptide nitrile derivatives as inhibitors of cathepsin l and cathepsin
GB9903861D0 (en) 1999-02-20 1999-04-14 Zeneca Ltd Chemical compounds
WO2000051998A1 (en) 1999-03-02 2000-09-08 Boehringer Ingelheim Pharmaceuticals, Inc. Compounds useful as reversible inhibitors of cathepsin s
TW200404789A (en) 1999-03-15 2004-04-01 Axys Pharm Inc Novel compounds and compositions as protease inhibitors
HK1039110A1 (zh) 1999-03-15 2002-04-12 Axys Pharmaceuticals, Inc. 以新颖的合成物及组分作为蛋白酶抑制剂
CN1362947A (zh) 1999-03-15 2002-08-07 Axys药物公司 用作蛋白酶抑制剂的n－氰基甲基酰胺
GB9907683D0 (en) 1999-04-06 1999-05-26 Synphar Lab Inc Substituted azetidin-2-ones as cysteine protease inhibitors
GB9911417D0 (en) 1999-05-18 1999-07-14 Peptide Therapeutics Ltd Furanone derivatives as inhibitors of cathepsin s
GB9917909D0 (en) 1999-07-31 1999-09-29 Synphar Lab Inc Cysteine protease inhibitors
JP4203241B2 (ja) 1999-08-03 2008-12-24 シーメンス アクチエンゲゼルシヤフト 電気機械的開閉装置のスイッチオフ遅延回路
YU17402A (sh) 1999-09-13 2004-11-25 Boehringer Ingelheim Pharmaceuticals Inc. Nova spiroheterociklična jedinjenja upotrebljiva kao reverzibilni inhibitori cisteinskih proteaza
US6420364B1 (en) 1999-09-13 2002-07-16 Boehringer Ingelheim Pharmaceuticals, Inc. Compound useful as reversible inhibitors of cysteine proteases
CA2384974A1 (en) 1999-09-16 2001-03-22 Axys Pharmaceuticals, Inc. Compounds and pharmaceutical compositions as cathepsin s inhibitors
GB9925264D0 (en) 1999-10-26 1999-12-29 Zeneca Ltd Chemical compounds
JP2003513921A (ja) 1999-11-10 2003-04-15 スミスクライン・ビーチャム・コーポレイション プロテア−ゼ阻害剤
WO2001034160A1 (en) 1999-11-10 2001-05-17 Smithkline Beecham Corporation Protease inhibitors
AU783145B2 (en) 1999-12-24 2005-09-29 F. Hoffmann-La Roche Ag Nitrile derivatives as cathepsin K inhibitors
WO2001049288A1 (en) 2000-01-06 2001-07-12 Merck Frosst Canada & Co. Novel compounds and compositions as protease inhibitors
GB0003111D0 (en) 2000-02-10 2000-03-29 Novartis Ag Organic compounds
WO2001068645A2 (en) 2000-03-15 2001-09-20 Axys Pharmaceuticals, Inc. N-cyanomethylcarboxamides and their use as protease inhibitors
KR20020082896A (ko) 2000-03-21 2002-10-31 스미스클라인 비참 코포레이션 프로테아제 억제제
WO2001077073A1 (en) 2000-04-06 2001-10-18 Merck Frosst Canada & Co. Cathepsin cysteine protease inhibitors
CO5280093A1 (es) 2000-04-18 2003-05-30 Smithkline Beecham Corp Metodos de tratamiento
US6462076B2 (en) 2000-06-14 2002-10-08 Hoffmann-La Roche Inc. Beta-amino acid nitrile derivatives as cathepsin K inhibitors
AU2001268407A1 (en) 2000-06-14 2001-12-24 Smithkline Beecham Corporation Protease inhibitors
JP2004509083A (ja) 2000-09-01 2004-03-25 スミスクライン・ビーチャム・コーポレイション 治療方法
EP1326848A1 (en) 2000-10-19 2003-07-16 Naeja Pharmaceutical Inc. Dihydropyrimidine derivatives as cysteine protease inhibitors
JP2004523506A (ja) 2000-12-22 2004-08-05 アクシス・ファーマシューティカルズ・インコーポレイテッド カテプシン阻害剤としての新規な化合物と組成物
US7425562B2 (en) * 2001-01-17 2008-09-16 Amura Therapeutics Ltd. Inhibitors of cruzipain and other cysteine proteases
JP2004520365A (ja) 2001-01-17 2004-07-08 アミュラ テラピューティクス リミテッド クルジパインおよび他のシステインプロテアーゼの阻害剤
WO2002080920A1 (en) 2001-04-06 2002-10-17 Axys Pharmaceuticals, Inc. Arylacetamido-ketobenzoxazole as cysteine protease inhibitors
EP1401453A4 (en) 2001-05-17 2005-04-06 Smithkline Beecham Corp PROTEASE INHIBITORS
FR2826572B1 (fr) 2001-06-29 2005-10-07 Oreal Compositions contenant un derive d'hydroxydiphenyl ether inhibant le developpement des odeurs corporelles
EP1411933A1 (en) 2001-08-03 2004-04-28 SmithKline Beecham Corporation Alpha-ketoamide derivatives as cathepsin k inhibitors
AR036375A1 (es) 2001-08-30 2004-09-01 Novartis Ag Compuestos pirrolo [2,3-d] pirimidina -2- carbonitrilo, un proceso para su preparacion, una composicion farmaceutica y el uso de dichos compuestos para la preparacion de medicamentos
EP1436255A1 (en) 2001-09-14 2004-07-14 Aventis Pharmaceuticals, Inc. Novel compounds and compositions as cathepsin inhibitors
AU2002340031A1 (en) 2001-10-02 2003-04-14 Boehringer Ingelheim Pharmaceuticals, Inc. Compounds useful as reversible inhibitors of cysteine proteases
CA2463770A1 (en) 2001-10-29 2003-05-08 Boehringer Ingelheim Pharmaceuticals, Inc. Compounds useful as reversible inhibitors of cysteine proteases
AU2002352663B2 (en) 2001-11-13 2007-06-21 Axys Pharmaceuticals, Inc. Cyanoalkylamino derivatives as protease inhibitors
YU34604A (sh) 2001-11-14 2006-08-17 Aventis Pharmaceuticals Inc. Oligopeptidi kao inhibitori katepsina s i kompozicije koje ih sadrže
DE60326473D1 (en) 2002-07-16 2009-04-16 Amura Therapeutics Ltd Pyrrolderivate als hemmstoffe von cystein proteasen
BRPI0506719A (pt) * 2004-01-08 2007-05-02 Medivir Ab composto, composição farmacêutica, e, uso de um composto
WO2006064286A1 (en) 2004-12-13 2006-06-22 Medivir Uk Ltd Cathepsin s inhibitors
GB0614044D0 (en) * 2006-07-14 2006-08-23 Amura Therapeutics Ltd Compounds
GB0614042D0 (en) * 2006-07-14 2006-08-23 Amura Therapeutics Ltd Compounds

Similar Documents

Publication Publication Date Title
JP2011509282A5 (https=)
US12377097B2 (en) Aminopyrimidine amide autophagy inhibitors and methods of use thereof
Ries et al. Heterocyclic thrombin inhibitors. Part 2: quinoxalinone derivatives as novel, potent antithrombotic agents
US7638627B2 (en) Process of preparing imatinib and imatinib prepared thereby
TW200745111A (en) New compounds
US9359376B2 (en) Substituted methylformyl reagents and method of using same to modify physicochemical and/or pharmacokinetic properties of compounds
JP2010526129A5 (https=)
UA81635C2 (en) 2,5-dioxoimidazolidin-4-yl acetamides and analogues as inhibitors of metalloproteinase mmp12.
MY130803A (en) New quinuclidine amide derivatives
BR112020014160A2 (pt) Compostos de benzamida
JP2005519908A5 (https=)
NO20051695L (no) Nye spirokondenserte kinazolinoner og deres anvendelse som fosfodiestereaseinbibitorer
DE602004024375D1 (de) Carboxamidderivate
JP2010532387A5 (https=)
JP2006509000A5 (https=)
NO20070837L (no) Pyrido-pyrido pyrimidinderivater, fremstilling derav samt terapeutisk anvendelse for behandling av cancer.
MY145613A (en) Novel compounds
ATE307810T1 (de) Imidazol-2-carbonsäureamid derivate als raf- kinase-inhibitoren
BRPI0413393A (pt) fexofenadina, composição farmaceuticamente aceitável, método de tratamento antihistamìnico, composição, processo para preparar fexofenadina e uso de fexofenadina
CN110312531A (zh) 治疗性树枝状体
JP2012513390A5 (https=)
RU98108553A (ru) Фармацевтические композиции, содержащие производные гидроксимикоевой кислоты
MXPA04002338A (es) Derivados de carbazol y su uso como antagonistas receptores del npy5.
MX2009010165A (es) Nuevas imidazo[4,5-b]piridina-7-carboxamidas 704.
GB0109122D0 (en) Novel compounds